Hospital da Luz Lisboa, S.A.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Type 2 diabetes1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Novo Nordisk A/S2 trials

Closed trials

• Completed

  A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)

  NCT05646706· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight

  NCT05649137· Phase 3· Novo Nordisk A/S· Source